variety radiopharmaceuticals introduced internal therapy malignant inflammatory lesions nuclear medicine order destroy diseased tissues radionuclides high linear energy transfer let beta alpha auger low energy conversion electron emitters needed range beta particles mms effective large tumors range alpha particles short cell diameters effective treating circulating malignant cells micrometastases range auger conversion electrons NUMBER micro m effective cell killing carried cell membrane nucleus damage dna appropriate ions molecules particles labelled radionuclides used radiopharmaceuticals different applications effective dose delivered high target non target ratios attained monoclonal antibodies specific antigens expressed tumor cells developed increase uptake malignant tissues specific accumulation radiolabelled peptides somatostatin small molecules mibg different microparticles investigated effectiveness therapy increased direct locoregional administration radiopharmaceutical way radiation effects confined locally normal tissues spared radiation effects review article selection criteria characteristics radionuclides carrier ions molecules particles various therapeutic applications discussed including mainly recent developments references NUMBER metaiodo benzylguanidine nano